Stone House Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
294
+205
+230% +$209K 0.05% 62
2026
Q1
$82K Buy
89
+8
+10% +$8.11K 0.01% 135
2025
Q4
$87.1K Sell
81
-16
-16% -$15.3K 0.01% 125
2025
Q3
$74K Hold
97
– – 0.01% 128
2025
Q2
$75.6K Sell
97
-13
-12% -$10.1K 0.01% 123
2025
Q1
$90.8K Buy
+110
New +$91.5K 0.02% 100
2024
Q4
– Sell
-161
Closed -$142K – 216
2024
Q3
$142K Sell
161
-40
-20% -$36K 0.03% 58
2024
Q2
$182K Buy
201
+75
+60% +$60K 0.05% 54
2024
Q1
$97.7K Buy
126
+51
+68% +$36.3K 0.02% 85
2023
Q4
$43.5K Buy
75
+1
+1% +$584 0.02% 90
2023
Q3
$40K Sell
74
-5
-6% -$2.58K 0.01% 89
2023
Q2
$37.2K Sell
79
-59
-43% -$24.7K 0.01% 90
2023
Q1
$47.5K Buy
+138
New +$46.5K 0.02% 92
2019
Q2
– Sell
-36
Closed -$5K – 130
2019
Q1
$5K Buy
+36
New +$4.38K ﹤0.01% 180

Other funds holding LLY

Stone House Investment Management's LLY Position: Q2 2026 in Review

Stone House Investment Management increased its Eli Lilly (LLY) stake by 230% in Q2 2026, buying an estimated $209K and bringing the position to 294 shares worth $352K. The position accounts for 0.05% of the portfolio, ranked #62.

Stone House Investment Management first reported a position in LLY in Q1 2019 and has held it in 14 quarters since. 4,643 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stone House Investment Management held 294 shares of Eli Lilly worth $352K as of Q2 2026.
  • Stone House Investment Management bought 205 Eli Lilly shares in Q2 2026, an estimated $209K.
  • Eli Lilly made up 0.05% of Stone House Investment Management's portfolio in Q2 2026, its #62 holding.
  • Stone House Investment Management first reported a position in Eli Lilly in Q1 2019 and has held it in 14 quarters since.
  • 4,643 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.